Nasal Drug Delivery Technology Global Market Report 2023: Major Players Include AptarGroup, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer and 3M

DUBLIN, June 23, 2023 /PRNewswire/ -- The "Nasal Drug Delivery Technology Global Market Report 2023" report has been added to  ResearchAndMarkets.com's offering.

This report provides strategists, marketers, and senior management with the critical information they need to assess the nasal drug delivery technology market.

The global nasal drug delivery technology market is expected to grow from $72.16 billion in 2022 to $77.42 billion in 2023 at a compound annual growth rate (CAGR) of 7.29%. The nasal drug delivery technology market is expected to reach $101.49 billion in 2027 at a CAGR of 7%.

Major players in the nasal drug delivery technology market are AptarGroup Inc., Becton, Dickinson and Company, GlaxoSmithKline Plc, Johnson & Johnson Private Limited, Novartis AG, Pfizer Inc., 3M Co., Cadila Pharmaceuticals, Neurelis Inc., OptiNose Inc., Bausch Health Companies Inc., Naveh Pharma Ltd., Teva Pharmaceutical Industries Ltd., Consort Medical plc, Douglas Pharmaceuticals Ltd., and ENT Technologies Pty. Ltd.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the COVID-19 and how it is likely to emerge and grow as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The nasal drug delivery technology refers to administering pharmaceuticals through the nasal cavity to attain therapeutic drug levels in the blood as quickly as possible and the potential for direct drug delivery to the brain via the olfactory neurons. Nasal drug delivery methods circumvent the blood-brain barrier (BBB) and undergo minimal hepatic and intestinal processing.

The main type of dosage forms for nasal drug delivery technology include nasal spray, nasal drops, nasal gels and ointments, nasal powders, and others. Nasal spray refers to nasal drug delivery devices that force a large quantity of tiny liquid drops to cleanse the nose or administer medication to the body.

It is available in two main types of containers that are pressurized and non-pressurized and is used in various applications such as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination, and others. It is available through various distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and is being used by end-users such as home care settings and hospitals.

Product innovations are a key trend gaining popularity in the nasal drug delivery technology market. Major pharmaceutical companies operating in the nasal drug delivery technology market are involved in developing new and improved products to provide their customers with new methods of drug administration to sustain their position in the market.

For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, launched the first recyclable, metal-free, multidose nasal spray, APF Futurity, to deliver nasal saline and other equivalent over-the-counter (OTC) formulations. APF Futurity is manufactured from polyolefin materials and does not include any metal components or recycling disruptors. This reduces the need for separation in recycling streams and promotes a greater grade of recycled materials. This product's unique feature is its recyclability design; it is a highly recyclable nasal spray pump that has received Class AA certification from cyclos-HTP for recycling streams in Europe.

In May 2022, Medtronic plc, a US-based medical device firm, acquired Intersect ENT Inc. for an undisclosed sum. The acquisition will add novel products used in sinus operations to enhance post-operative outcomes and treat nasal polyps to Medtronic's entire ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical device firm operating in ear, nose, and throat medical technology.

North America was the largest region in the nasal drug delivery technology market in 2022. The regions covered in nasal drug delivery technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nasal drug delivery technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The increasing incidences of chronic diseases are expected to propel the growth of the nasal drug delivery technology market going forward. Chronic diseases can be defined as conditions that last 1 year or more and require ongoing medical attention, limit activities of daily living, or both. Nasal drug delivery technologies are used for the management of chronic rhinosinusitis to improve the bacterial biofilm or mucociliary clearance due to the complex structure of the nasal cavity through a therapeutic nasal cavity strategy.

For instance, in September 2022, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing incidences of chronic diseases are driving the growth of the market for nasal drug delivery systems.

The nasal drug delivery technology market consists of revenues earned by entities by providing services such as intranasal drug delivery services, brain targeted therapy and mucosal vaccination. The market value includes the value of related goods sold by the service provider or included within the service offering.

The nasal drug delivery technology market also includes sales of catheter-delivered drugs, nebulizers, and pressurized metered-dose inhalers (PMDIs) equipment which are used in providing nasal drug delivery technology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Key Topics Covered:

1. Executive Summary

2. Nasal Drug Delivery Technology Market Characteristics

3. Nasal Drug Delivery Technology Market Trends And Strategies

4. Nasal Drug Delivery Technology Market - Macro Economic Scenario
4.1. COVID-19 Impact On Nasal Drug Delivery Technology Market
4.2. Ukraine-Russia War Impact On Nasal Drug Delivery Technology Market
4.3. Impact Of High Inflation On Nasal Drug Delivery Technology Market

5. Nasal Drug Delivery Technology Market Size And Growth
5.1. Global Nasal Drug Delivery Technology Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Nasal Drug Delivery Technology Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Nasal Drug Delivery Technology Market Segmentation
6.1. Global Nasal Drug Delivery Technology Market, Segmentation By Dosage Form, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Nasal Spray
• Nasal Drops
• Nasal Gels And Ointments
• Nasal Powders
• Other Dosage Forms

6.2. Global Nasal Drug Delivery Technology Market, Segmentation By Container Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Pressurized Containers
• Non-Pressurized Containers

6.3. Global Nasal Drug Delivery Technology Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Allergic And Non-Allergic Rhinitis
• Nasal Congestion
• Asthma
• Vaccination
• Other Therapeutic Applications

6.4. Global Nasal Drug Delivery Technology Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

6.5. Global Nasal Drug Delivery Technology Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Home Care Settings
• Hospitals

7. Nasal Drug Delivery Technology Market Regional And Country Analysis
7.1. Global Nasal Drug Delivery Technology Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Nasal Drug Delivery Technology Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/ncis3

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets